High ROI:
Generate a high return on
investment.
Yearly savings can be in the millions.
 


Save time and resources
by prioritising
what to screen next.
 


 “Rule of 5”:
see further details
 

Benefits for you

    Lead selection and prioritisation of drug candidates
    MolScore-products helps to identify and prioritise promising drug candidates with the maximum possibility of success in human trials, see lead selection & prioritisation.

    Predicting ADMET-profiles
    Our large ADME/Tox-database enables us to develop reliable tools to predict ADME/Tox-properties in order to identify and prioritise promising drug candidates.

    Customised expert systems
    PharmaInformatic develops tailor-made expert systems for the specific needs of our customers. These expert systems help to discover and select drug candidates in customer-specific therapeutic areas. For further information, please contact us.

    Selection of compounds from external suppliers
    External substances are very expensive and only a small amount of them are useful for further research, see analysing compound databases. Selecting substances with a high probability of success saves a significant amount of money.

    Selection of compounds before chemical synthesis
    The chemical synthesis of compounds is expensive and takes a lot of time, even if combinatorial chemistry or automated synthesis are used. Check out the possibility of success before synthesising candidates. Further on our expert systems can analyse and prioritise virtual combinatorial libraries. Identify the most useful compounds before synthesising them.

    MolScore-products versus “Rule of 5”
    The “Rule of 5” is a good start to focus screenings efforts, however, a significant number of potential drugs are missed. Complex drug patterns are detected by our expert systems. MolScore-products have a prediction ability which can exceed 95%. This helps to select and prioritise useful compounds and increase the success of research.

Focussed libraries for High Throughput Screening
Our expert systems are proven to increase the success of HTS campaigns and will make HTS even more reliable. By focussing on compounds for your specific field of research, it is possible to secure the same number of hits while testing far fewer compounds, see increasing the hit-rate (case study).

© Copyright 2004-2010 PharmaInformatic Boomgaarden. All rights reserved.         Site map             Contact         Terms of Use         Imprint        

 
Why screen everything?

Save time and money by smart screening
 

 
Buying external compounds?

Get advice in selecting the right compounds for your needs!